BR0013665A - Uso de uma proteìna histacalina, composição farmacêutica, e, método de tratar ou impedir conjuntivite - Google Patents

Uso de uma proteìna histacalina, composição farmacêutica, e, método de tratar ou impedir conjuntivite

Info

Publication number
BR0013665A
BR0013665A BR0013665-4A BR0013665A BR0013665A BR 0013665 A BR0013665 A BR 0013665A BR 0013665 A BR0013665 A BR 0013665A BR 0013665 A BR0013665 A BR 0013665A
Authority
BR
Brazil
Prior art keywords
histacaline
protein
treating
pharmaceutical composition
conjunctivitis
Prior art date
Application number
BR0013665-4A
Other languages
English (en)
Inventor
Patricia Anne Nuttall
Guido Christiaan Paesen
Original Assignee
Evolutec Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Evolutec Ltd filed Critical Evolutec Ltd
Publication of BR0013665A publication Critical patent/BR0013665A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1767—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/855—Proteins from animals other than mammals or birds
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/855—Proteins from animals other than mammals or birds
    • Y10S530/858—Proteins from animals other than mammals or birds insects; venom

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Ophthalmology & Optometry (AREA)
  • Zoology (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Polarising Elements (AREA)
  • Surface Treatment Of Glass (AREA)

Abstract

"USO DE UMA PROTEìNA HISTACALINA, COMPOSIçãO FARMACêUTICA, E, MéTODO DE TRATAR OU IMPEDIR CONJUNTIVITE". A presente invenção refere-se à verificação de que várias proteínas isoladas de carrapatos são eficazes no tratamento da conjuntivite. Estas proteínas podem muito adequadamente ser aplicadas topicamente a uma área afetada e são eficazes para melhorar os sintomas desta condição.
BR0013665-4A 1999-09-01 2000-08-24 Uso de uma proteìna histacalina, composição farmacêutica, e, método de tratar ou impedir conjuntivite BR0013665A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9920674.0A GB9920674D0 (en) 1999-09-01 1999-09-01 Treatment of conjunctivitis
PCT/GB2000/003282 WO2001015719A2 (en) 1999-09-01 2000-08-24 Treatment of conjunctivitis

Publications (1)

Publication Number Publication Date
BR0013665A true BR0013665A (pt) 2002-05-14

Family

ID=10860170

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0013665-4A BR0013665A (pt) 1999-09-01 2000-08-24 Uso de uma proteìna histacalina, composição farmacêutica, e, método de tratar ou impedir conjuntivite

Country Status (17)

Country Link
US (1) US6737399B2 (pt)
EP (1) EP1207898B1 (pt)
JP (1) JP2003508445A (pt)
CN (1) CN1382057A (pt)
AT (1) ATE289203T1 (pt)
AU (1) AU780773B2 (pt)
BR (1) BR0013665A (pt)
CA (1) CA2382473A1 (pt)
DE (1) DE60018192T2 (pt)
DK (1) DK1207898T3 (pt)
ES (1) ES2235930T3 (pt)
GB (1) GB9920674D0 (pt)
HK (1) HK1046362B (pt)
MX (1) MXPA02001807A (pt)
NZ (1) NZ517218A (pt)
PT (1) PT1207898E (pt)
WO (1) WO2001015719A2 (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0307544D0 (en) * 2003-04-01 2003-05-07 Evolutec Ltd Treatment method
GB0809279D0 (en) * 2008-05-21 2008-06-25 Varleigh Ltd Histamine binding protein
EP3353304B1 (en) * 2015-09-25 2022-10-19 Okogen, Inc. Viral conjunctivitis treatment using ranpirnase
GB201720505D0 (en) * 2017-12-08 2018-01-24 Volution Immuno Pharmaceuticals Sa Methods for treatment of neuropathic pain

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2236807T3 (es) * 1996-05-18 2005-07-16 Evolutec Limited Moleculas de union de aminas vasoactivas.
PL340728A1 (en) * 1997-11-26 2001-02-26 Oxford Vacs Ltd Histamine and serotonin bonding molecules

Also Published As

Publication number Publication date
DK1207898T3 (da) 2005-06-13
HK1046362B (zh) 2005-09-02
JP2003508445A (ja) 2003-03-04
CN1382057A (zh) 2002-11-27
WO2001015719A2 (en) 2001-03-08
HK1046362A1 (en) 2003-01-10
EP1207898A2 (en) 2002-05-29
EP1207898B1 (en) 2005-02-16
PT1207898E (pt) 2005-05-31
DE60018192T2 (de) 2005-12-29
CA2382473A1 (en) 2001-03-08
ATE289203T1 (de) 2005-03-15
NZ517218A (en) 2004-10-29
AU780773B2 (en) 2005-04-14
MXPA02001807A (es) 2003-07-14
DE60018192D1 (de) 2005-03-24
AU6713900A (en) 2001-03-26
WO2001015719A3 (en) 2001-05-10
GB9920674D0 (en) 1999-11-03
US6737399B2 (en) 2004-05-18
US20020151499A1 (en) 2002-10-17
ES2235930T3 (es) 2005-07-16

Similar Documents

Publication Publication Date Title
TNSN00010A1 (fr) DIPHENYLUREE A SUBSTITUTION ω CARBOXYARYLE SERVANT D'INHIBUTEURS DE RAF KINASE.
DE69826695D1 (de) Arylharnstoffderivate zur behandlung von inflammatorischen oder immunomodulatorischen erkrankungen
EP1408986A4 (en) PROTEOMIMETIC COMPOUNDS AND CORRESPONDING METHODS
TR200002773T2 (tr) Alzheimer tedavisi için smilagenin ve anzurogenin-D ve bunların kullanımı.
NO995544L (no) Forbindelser og metoder for inhibering av ekspresjonen av VCAM-1
NO20025450D0 (no) Ny farmasöytisk sammensetning
DE60327999D1 (de) Azolylaminoazine als inhibitoren von proteinkinasen
EA200401471A1 (ru) Применение ингибиторов сетр и возможных ингибиторов hmg coa и/или антигипертензивных агентов
DE69821667D1 (de) Kardioverter zur Behandlung von Vorhofflattern
DK0662948T3 (da) 2-amino-4-phenyl-4-oxosmørsyrederivater med kynureninase- og/eller kynurenin-3-hydroxylaseinhiberende virkning
ATE234111T1 (de) Therapeutische verwendungen von bpi-protein produkten bei menschen mit durch trauma verursachter blutung
TR200101756T2 (tr) Protein kinaz inhibitörleri olarak 4,5-pirazinoksindoller.
DK1032556T3 (da) Farmaceutisk aktive forbindelser og anvendelsesfremgangsmåder
ATE271873T1 (de) Verwendung von glukosamin und glukosaminderivaten zur schnellen linderung von juckreiz oder lokalisiertem schmerz
WO2000078795A3 (en) Rufomycins and derivatives thereof useful as inhibitors of multi-drug resistance associated protein-1 (mrp-1)
ATE305311T1 (de) Zusammensetzung zur behandlung von herzinsuffizienz
ATE290857T1 (de) Bretyliumhaltige zusammensetzungen und kits und deren verwendung zur vorbeugung und behandlung cardiovaskulärer erkrankungen
BR0013665A (pt) Uso de uma proteìna histacalina, composição farmacêutica, e, método de tratar ou impedir conjuntivite
PT1207899E (pt) Tratamento da rinite alergica com certas proteinas de ligacao de aminas vasoactivas
ATE238796T1 (de) Nukleosidderivative in kombinationspräparaten zur behandlung von hsv krankheiten
PT1103270E (pt) Tratamento de doencas auto-imunes em mamiferos
TR199902914T2 (xx) �zole sistolik hipertansiyonu tedavi y�ntemi.
ATE262527T1 (de) Zur vorbeugung oder behandlung von östrogenabhängigen krankheiten nützliche pyrrolo(2.1.5-cd)indolizin-derivate
ITMI961070A0 (it) Prevenzione e trattamento delle infezioni virali topiche con perfluoropolietere o loro composizioni.
BR1101180A (pt) formulação para tratamento de sintomas e doenças.

Legal Events

Date Code Title Description
B25G Requested change of headquarter approved

Owner name: EVOLUTEC LIMITED (GB)

Free format text: SEDE ALTERADA CONFORME SOLICITADO NA PETICAO NO 020060062216/RJ DE 03/05/2006.

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 8A E 9A ANUIDADES

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 DA RPI 2008 DE 30/06/2009.